Goldenseal (Hydrastis canadensis)

Table of Contents

  1. Native American History and Traditional Use
  2. Key Antibacterial Compounds
  3. Mechanism of Antibacterial Action
  4. Bacteria Targeted by Goldenseal
  5. Research Studies and Clinical Evidence
  6. Urinary Tract Infection Applications
  7. Gastrointestinal Antibacterial Uses
  8. Eye and Skin Infections
  9. MRSA and Antibiotic-Resistant Bacteria Research
  10. Synergistic Effects with Other Herbs
  11. Conservation Status and Sustainability
  12. Other Health Benefits
  13. Forms and Preparations
  14. Recommended Dosage
  15. Safety and Contraindications
  16. Key Research Papers and References
  17. Featured Videos

Native American History and Traditional Use

Goldenseal has been a cornerstone of Native American medicine for centuries, earning the common name "yellow root" from its bright yellow rhizome, which was prized as both a medicine and a dye. The Cherokee nation used goldenseal extensively as a wash for skin diseases, wounds, and sore eyes, and prepared decoctions of the root to treat general debility, dyspepsia, and to improve appetite. Cherokee healers combined goldenseal with bear grease to create insect repellent preparations and used the root internally for fevers, whooping cough, and liver and stomach disorders.

The Iroquois Confederacy similarly valued goldenseal as a powerful medicinal plant. Iroquois medicine practitioners prepared infusions of the root for treating ear infections, liver ailments, and stomach troubles. They also used it as a wash for sore eyes, a practice that would persist for centuries among both indigenous and settler communities. The Iroquois recognized goldenseal's bitter properties as indicative of its ability to combat infections and digestive complaints, and they passed this knowledge through oral tradition for generations.

Other tribes, including the Micmac, Chippewa, and Potawatomi, incorporated goldenseal into their pharmacopeias for treating ulcers, gonorrhea, arrow wounds, and cancerous growths. European settlers quickly adopted goldenseal from Native American practitioners in the late 18th century. By the early 1800s, the Eclectic physicians -- a school of American botanical medicine -- had elevated goldenseal to one of their most frequently prescribed remedies. The Eclectics used it primarily for mucous membrane inflammation, earning it the reputation as a premier treatment for catarrhal conditions of the respiratory, digestive, and urogenital tracts. This widespread use, combined with habitat loss, led to severe overharvesting that continues to threaten wild populations today.

Key Antibacterial Compounds

Goldenseal's antibacterial potency derives from a group of isoquinoline alkaloids concentrated in its rhizome and roots. These alkaloids work both independently and synergistically to combat a broad spectrum of bacterial pathogens.

Berberine

Berberine is the primary bioactive alkaloid in goldenseal, typically comprising 2.5-6% of the dried root by weight. This bright yellow quaternary ammonium compound belongs to the protoberberine class of isoquinoline alkaloids and has been the subject of over 5,000 published scientific studies. Berberine demonstrates broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, making it one of the most versatile plant-derived antimicrobial agents known. Its mechanism of action is multifaceted, targeting bacterial DNA synthesis, protein production, and cell membrane integrity simultaneously, which makes it difficult for bacteria to develop resistance to it through single-point mutations.

Hydrastine

Hydrastine is the second most abundant alkaloid in goldenseal, present at concentrations of 1.5-4% of the dried root. This phthalideisoquinoline alkaloid contributes significantly to goldenseal's overall antimicrobial profile. While hydrastine's direct antibacterial activity is less potent than berberine's when tested in isolation, research has demonstrated that it substantially enhances berberine's effectiveness through synergistic interaction. Hydrastine appears to inhibit bacterial multidrug resistance (MDR) efflux pumps, particularly the NorA pump found in Staphylococcus aureus. By blocking these pumps, hydrastine prevents bacteria from expelling berberine from their cells, thereby increasing berberine's intracellular concentration and amplifying its killing power. This partnership between the two alkaloids is a prime example of the "entourage effect" in botanical medicine.

Canadine (Tetrahydroberberine)

Canadine, also known as tetrahydroberberine, is the third major alkaloid found in goldenseal root, typically present at 0.5-1% concentration. Canadine is structurally related to berberine but possesses a fully reduced ring system. While it shows moderate direct antibacterial activity, canadine's primary contribution to goldenseal's antimicrobial profile lies in its role as an efflux pump inhibitor, similar to hydrastine. Research published in the Journal of Natural Products demonstrated that canadine potently inhibits the NorA efflux pump in staphylococcal species, reducing the minimum inhibitory concentration (MIC) of berberine by 4- to 16-fold when the two compounds are combined. Additionally, canadine exhibits anti-inflammatory properties that may help the body's immune system work more effectively alongside the direct antibacterial action of the other alkaloids.

Mechanism of Antibacterial Action

Goldenseal's antibacterial activity operates through multiple sophisticated mechanisms, making it effective against a wide range of bacterial pathogens and reducing the likelihood of resistance development.

DNA Intercalation and Replication Inhibition

Berberine acts as a DNA intercalating agent, inserting itself between the base pairs of bacterial DNA double helices. This intercalation distorts the DNA structure, inhibiting the activity of DNA topoisomerase enzymes that are essential for bacterial DNA replication and transcription. Studies published in Antimicrobial Agents and Chemotherapy have shown that berberine specifically inhibits bacterial type II topoisomerase (DNA gyrase) at concentrations achievable through oral supplementation. By blocking DNA gyrase, berberine halts bacterial cell division and prevents the expression of virulence genes. This mechanism is analogous to that of fluoroquinolone antibiotics, though berberine targets different binding sites on the enzyme, explaining why cross-resistance between berberine and fluoroquinolones has not been observed.

FtsZ Protein Inhibition

One of berberine's most significant antibacterial mechanisms involves the inhibition of FtsZ, a key bacterial cell division protein. FtsZ is a tubulin-like GTPase that assembles into a ring structure (the Z-ring) at the midpoint of a dividing bacterial cell, driving the constriction that separates daughter cells. Research published in Biochemistry demonstrated that berberine binds directly to FtsZ, inhibiting its GTPase activity and preventing proper Z-ring assembly. Without functional FtsZ, bacteria cannot complete cell division, leading to the formation of elongated, non-viable filamentous cells that ultimately die. This mechanism is particularly significant because FtsZ is present in nearly all bacteria but has no human homolog, meaning it represents a highly selective antibacterial target with minimal risk of host toxicity.

Efflux Pump Inhibition

The goldenseal whole-root extract demonstrates a remarkable strategy of self-potentiation through efflux pump inhibition. Many bacteria, including Staphylococcus aureus and Escherichia coli, express membrane-bound efflux pumps (such as NorA, MexAB-OprM, and AcrAB-TolC) that actively expel antimicrobial compounds from the bacterial cell, conferring multidrug resistance. Goldenseal's minor alkaloids, particularly hydrastine and canadine, function as potent inhibitors of these efflux pumps. Research by Stermitz and colleagues at Colorado State University demonstrated that the concentration of berberine alone required to inhibit S. aureus growth was reduced by 16-fold when combined with the efflux pump inhibitor 5'-methoxyhydnocarpin (5'-MHC), another component found in plants containing berberine. This finding explains why goldenseal whole-root extracts are often more effective than isolated berberine, as the plant produces its own efflux pump inhibitors alongside its primary antibacterial alkaloid.

Bacteria Targeted by Goldenseal

Goldenseal and its constituent alkaloids have demonstrated antibacterial activity against a wide array of clinically significant pathogens. The following bacteria have been studied in controlled laboratory and, in some cases, clinical settings.

Gram-Positive Bacteria

Gram-Negative Bacteria

Research Studies and Clinical Evidence

The antibacterial properties of goldenseal and berberine have been documented in hundreds of peer-reviewed studies spanning several decades. The body of evidence ranges from in vitro laboratory studies to animal models and a growing number of human clinical trials.

A landmark study published in Planta Medica by Scazzocchio and colleagues evaluated the antimicrobial activity of Hydrastis canadensis extract against a panel of clinical bacterial isolates. The researchers found that goldenseal whole-root extract demonstrated significantly greater antibacterial activity than equivalent concentrations of purified berberine alone, providing the first strong evidence for the synergistic interaction between goldenseal's multiple alkaloids. This study was instrumental in shifting research focus from isolated berberine to whole-plant extracts.

Research published in the Journal of Ethnopharmacology systematically reviewed the traditional antimicrobial uses of goldenseal and evaluated them against modern pharmacological evidence. The review confirmed that the majority of goldenseal's traditional antibacterial applications were supported by at least in vitro evidence, including its use for eye infections, skin wounds, respiratory infections, and gastrointestinal complaints. The authors noted that goldenseal's alkaloid profile, combining a primary antimicrobial agent with synergistic efflux pump inhibitors, represented a sophisticated evolved chemical defense system.

A pivotal study in Antimicrobial Agents and Chemotherapy by Stermitz and colleagues at Colorado State University elucidated the efflux pump inhibition mechanism by which minor goldenseal alkaloids potentiate berberine's antibacterial activity. Their research demonstrated that the NorA efflux pump inhibitor 5'-methoxyhydnocarpin, found in berberine-producing plants, reduced the MIC of berberine against S. aureus by 16-fold. This work fundamentally changed understanding of how multi-component botanical medicines achieve their therapeutic effects and stimulated extensive further research into plant-derived efflux pump inhibitors.

Urinary Tract Infection Applications

Goldenseal has a long history of use in treating urinary tract infections, and modern research has begun to elucidate the mechanisms behind this traditional application. Uropathogenic Escherichia coli (UPEC) is responsible for approximately 80-90% of community-acquired UTIs, and berberine has demonstrated multiple mechanisms of action against this pathogen that extend beyond simple bactericidal activity.

Research has shown that berberine inhibits the adherence of UPEC to uroepithelial cells by interfering with type 1 fimbriae (pili), the hair-like structures that bacteria use to attach to the bladder wall. A study published in the Journal of Antimicrobial Chemotherapy demonstrated that sub-inhibitory concentrations of berberine reduced E. coli adhesion to human bladder epithelial cells by up to 70%. By preventing initial attachment, berberine disrupts the first and most critical step in UTI pathogenesis. Additionally, berberine has been shown to inhibit UPEC biofilm formation on urinary catheters and uroepithelial surfaces, which is relevant for both acute and recurrent UTI management.

Clinical evidence for berberine in UTI treatment includes a randomized controlled trial published in the Journal of Chemotherapy in which berberine sulfate, administered at 100 mg four times daily, significantly reduced bacteriuria and symptoms in women with recurrent UTIs compared to placebo. The trial reported a 60% reduction in UTI recurrence over the three-month follow-up period. While this study used purified berberine rather than goldenseal extract, naturopathic practitioners often prefer the whole root for its additional efflux pump inhibition and anti-inflammatory properties. Goldenseal is commonly combined with uva ursi (Arctostaphylos uva-ursi) and cranberry extract in naturopathic UTI protocols.

Gastrointestinal Antibacterial Uses

Goldenseal's applications in gastrointestinal health represent some of its best-documented traditional uses and are strongly supported by modern pharmacological research. Berberine's poor oral bioavailability, often cited as a limitation, actually becomes an advantage in gastrointestinal applications because higher concentrations of the alkaloid remain in the gut lumen where they can directly contact intestinal pathogens.

Berberine has been studied extensively for the treatment of bacterial diarrhea. A meta-analysis of clinical trials published in Phytomedicine found that berberine significantly reduced the duration of acute infectious diarrhea caused by E. coli, Vibrio cholerae, and Shigella species compared to placebo. The anti-diarrheal effect is attributable both to berberine's direct antibacterial activity and to its ability to inhibit bacterial enterotoxin-induced intestinal secretion. Berberine blocks the chloride ion channels activated by cholera toxin and heat-labile E. coli enterotoxin, reducing the fluid loss that drives diarrheal symptoms.

In the context of Clostridioides difficile infection, berberine's ability to inhibit toxin production is particularly valuable. C. difficile toxins A and B are responsible for the mucosal inflammation, epithelial damage, and fluid secretion that characterize pseudomembranous colitis. Research in Journal of Medical Microbiology demonstrated that berberine at sub-MIC concentrations reduced toxin A production by 70% and toxin B production by 60%. This toxin-inhibiting property, combined with direct bactericidal activity, makes goldenseal a promising adjunctive therapy for C. difficile infection, particularly in patients with recurrent disease.

Goldenseal has also attracted attention for its potential role in managing small intestinal bacterial overgrowth (SIBO). Herbal antimicrobial protocols containing berberine-rich botanicals have shown efficacy comparable to rifaximin in a retrospective study published in Global Advances in Health and Medicine. The study found that 46% of SIBO patients treated with herbal antimicrobials (including berberine-containing formulas) achieved a negative follow-up breath test, compared to 34% of patients treated with rifaximin alone.

Eye and Skin Infections

The use of goldenseal for eye infections is one of its oldest and most enduring traditional applications. Native American tribes, particularly the Cherokee and Iroquois, used goldenseal root decoctions as an eyewash for conjunctivitis, blepharitis, and other ocular inflammations. This practice was adopted by Eclectic physicians in the 19th century, and goldenseal eyewashes remained in the United States Pharmacopeia until the mid-20th century.

Modern research supports this traditional use. Berberine has demonstrated in vitro activity against common conjunctivitis-causing organisms, including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa. A clinical trial published in Indian Journal of Ophthalmology compared berberine sulfate eye drops to chloramphenicol in patients with acute bacterial conjunctivitis and found comparable cure rates between the two treatments, with berberine demonstrating fewer side effects. Additionally, berberine has been shown to inhibit the inflammatory cytokines interleukin-1 beta and tumor necrosis factor alpha in conjunctival epithelial cells, suggesting both antibacterial and anti-inflammatory benefits for ocular infections.

For skin infections and wound healing, goldenseal has been traditionally applied as a poultice, powder, or wash. The antibacterial activity of berberine against skin pathogens, particularly S. aureus and Streptococcus pyogenes, supports its use in managing infected wounds, impetigo, and cellulitis. Beyond direct antibacterial action, berberine promotes wound healing through several mechanisms: it stimulates keratinocyte migration, enhances collagen synthesis, increases angiogenesis at the wound site, and reduces the excessive inflammatory response that can delay healing in chronic wounds. A study in the Journal of Ethnopharmacology demonstrated that topical application of berberine to excisional wounds in animal models accelerated wound closure by 40% compared to untreated controls, with histological evidence of improved re-epithelialization and reduced bacterial load.

MRSA and Antibiotic-Resistant Bacteria Research

The global crisis of antibiotic resistance has driven renewed interest in goldenseal as a source of novel antimicrobial strategies. Methicillin-resistant Staphylococcus aureus (MRSA) infections represent a particularly urgent threat, causing an estimated 80,000 invasive infections and over 11,000 deaths annually in the United States alone. Goldenseal research has contributed to the understanding of how plant-derived compounds can overcome bacterial resistance mechanisms.

The most significant contribution of goldenseal research to the antibiotic resistance field has been the elucidation of efflux pump inhibition as a strategy for restoring antibiotic sensitivity. MRSA and other resistant bacteria frequently employ multidrug efflux pumps to expel antibiotics from their cells before the drugs can reach lethal intracellular concentrations. The discovery that goldenseal's minor alkaloids, hydrastine and canadine, function as efflux pump inhibitors has opened an entirely new avenue of antimicrobial drug development. Research published in the Proceedings of the National Academy of Sciences demonstrated that combining berberine with the NorA efflux pump inhibitor 5'-methoxyhydnocarpin restored sensitivity in resistant S. aureus strains, reducing the MIC of berberine to levels comparable to those seen against sensitive strains.

Subsequent studies have explored combining goldenseal alkaloids with conventional antibiotics to restore their efficacy against resistant organisms. A study in Phytotherapy Research showed that sub-inhibitory concentrations of berberine combined with oxacillin, ampicillin, or cefazolin demonstrated synergistic antibacterial activity against MRSA, reducing the MIC of these beta-lactam antibiotics by 4- to 8-fold. Similarly, berberine has been shown to potentiate the activity of fluoroquinolones, aminoglycosides, and tetracyclines against resistant gram-negative bacteria by inhibiting the AcrAB-TolC efflux pump system in E. coli and Klebsiella pneumoniae. These findings suggest that goldenseal-derived compounds could serve as antibiotic adjuvants, extending the clinical useful life of existing antibiotics.

Synergistic Effects with Other Herbs

Goldenseal is frequently combined with other medicinal herbs in traditional and modern clinical practice to enhance its antibacterial effects. Several of these combinations have been investigated scientifically and shown to produce genuinely synergistic interactions.

Goldenseal and Echinacea

The combination of goldenseal and echinacea is perhaps the most widely recognized herbal pairing in North American botanical medicine. While goldenseal provides direct antibacterial activity through its alkaloids, echinacea (Echinacea purpurea, E. angustifolia, E. pallida) enhances the immune system's ability to fight infection by stimulating phagocytosis, increasing natural killer cell activity, and promoting cytokine production. This dual approach of direct pathogen killing combined with immune enhancement creates a complementary therapeutic effect. Research in the Journal of Alternative and Complementary Medicine found that the combination extract reduced symptom severity and duration in upper respiratory tract infections more effectively than either herb alone. Commercial products combining these two herbs remain among the best-selling herbal supplements in the United States.

Goldenseal and Oregon Grape Root

Oregon grape root (Mahonia aquifolium) contains berberine along with its own unique alkaloid profile, including berbamine and oxyacanthine. When combined with goldenseal, Oregon grape root contributes additional efflux pump inhibitors and antimicrobial alkaloids that broaden the spectrum of activity. This combination is favored by herbalists when treating stubborn bacterial infections, as the diverse alkaloid profiles of the two plants present bacteria with multiple simultaneous challenges. Oregon grape root also serves as an ecological and ethical alternative to goldenseal in some formulations, as it is more abundant and less threatened in the wild.

Goldenseal and Barberry

Barberry (Berberis vulgaris) is another berberine-rich plant that synergizes well with goldenseal. Barberry contains berberine, berbamine, palmatine, and jatrorrhizine, each with its own antimicrobial profile. The combination of goldenseal and barberry provides a higher total berberine dose along with a broader spectrum of supporting alkaloids. Research in Phytomedicine demonstrated that combining multiple berberine-containing plant extracts produced synergistic antimicrobial effects against S. aureus and E. coli that exceeded what could be achieved by simply increasing the dose of any single extract. This synergy is attributed to the diverse array of efflux pump inhibitors present across the different plant species.

Conservation Status and Sustainability

Wild goldenseal populations have declined dramatically since the 18th century due to a combination of overharvesting for the medicinal trade and widespread habitat destruction. Goldenseal's native range spans the deciduous forests of eastern North America, from Vermont and southern Ontario south to Georgia and west to Arkansas and Minnesota. The plant requires specific growing conditions -- moist, rich, well-drained soil in deep shade under a mature hardwood canopy -- making it particularly vulnerable to forest fragmentation, logging, and land clearing for agriculture and development.

Goldenseal was listed on Appendix II of the Convention on International Trade in Endangered Species (CITES) in 1997, requiring export permits and monitoring of international trade volumes. Several U.S. states, including Maine, Connecticut, Georgia, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Tennessee, and Vermont, have listed goldenseal as an endangered, threatened, or vulnerable species under their own conservation statutes. The United Plant Savers organization has placed goldenseal on its "At Risk" list, the most urgent conservation category, and actively promotes cultivation as an alternative to wild harvesting.

Sustainable sourcing of goldenseal requires purchasing cultivated or "woods-grown" (simulated wild) root from reputable suppliers who can document their supply chain. Woods-grown goldenseal, cultivated under natural forest canopy conditions, produces alkaloid profiles comparable to wild-harvested root and is considered the gold standard for sustainable production. Some companies now offer organically certified, woods-grown goldenseal with verified chain of custody documentation. Consumers can also look for the Forest Grown Verification program or the United Plant Savers "Goldenseal Sanctuary" designation. The growing market for cultivated goldenseal has created economic incentives for forest conservation, as landowners can generate income from standing forest rather than clearing it for other uses.

Other Health Benefits

While goldenseal's antibacterial properties are its most studied attribute, the plant offers several additional health benefits that contribute to its therapeutic value.

Anti-Inflammatory Effects

Berberine is a potent inhibitor of the NF-kB inflammatory signaling pathway, one of the master regulators of the inflammatory response. By suppressing NF-kB activation, berberine reduces the production of pro-inflammatory cytokines including interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha. Research in the International Immunopharmacology journal demonstrated that berberine reduced inflammatory markers in animal models of colitis, arthritis, and atherosclerosis. These anti-inflammatory properties complement goldenseal's antibacterial effects, as many bacterial infections trigger excessive inflammatory responses that contribute to tissue damage and symptoms.

Immune System Modulation

Beyond its direct antibacterial activity, berberine has been shown to modulate immune function in ways that enhance the body's natural defenses. Berberine increases the production of interferon gamma by T-helper cells, enhances macrophage phagocytic activity, and stimulates the proliferation of natural killer cells. A study in International Immunopharmacology found that berberine-treated macrophages demonstrated a 3-fold increase in their ability to engulf and destroy intracellular bacterial pathogens. These immunomodulatory effects work alongside goldenseal's direct antibacterial action to provide a comprehensive anti-infective strategy.

Blood Sugar Regulation

Berberine has demonstrated significant hypoglycemic effects in clinical trials, with efficacy comparable to metformin in some studies. A meta-analysis of 14 randomized controlled trials published in the Journal of Ethnopharmacology found that berberine reduced fasting blood glucose, hemoglobin A1c, and triglyceride levels in patients with type 2 diabetes. Berberine activates AMP-activated protein kinase (AMPK), enhances insulin receptor sensitivity, and reduces hepatic glucose output. While these metabolic benefits are typically attributed to purified berberine supplements, goldenseal root preparations also contribute to glycemic control when used therapeutically.

Liver Support and Bile Flow

Goldenseal has traditionally been classified as a cholagogue, a substance that promotes bile flow. Berberine stimulates the secretion of bile acids from hepatocytes and promotes gallbladder contraction, enhancing fat digestion and the elimination of waste products through the biliary system. Research has also demonstrated hepatoprotective effects, with berberine reducing liver enzyme elevations and fibrosis in animal models of toxic and alcoholic liver injury. The Eclectic physicians considered goldenseal one of their most important remedies for liver congestion and jaundice, a use that aligns with these modern pharmacological findings.

Forms and Preparations

Goldenseal is available in numerous preparations, each with its own advantages for different therapeutic applications.

Recommended Dosage

Dosage of goldenseal varies depending on the preparation form, the specific condition being treated, and whether the product is standardized for berberine content. The following are general guidelines drawn from traditional use, clinical trials, and pharmacokinetic data.

Berberine Standardization

When selecting goldenseal products, berberine content serves as the primary marker for quality and potency. High-quality goldenseal root should contain a minimum of 2.5% berberine by weight, with premium cultivated roots reaching 5-6%. Products standardized to berberine content allow for more precise therapeutic dosing. For antibacterial applications, practitioners typically aim for a total daily berberine intake of 200-500 mg from goldenseal preparations. It is worth noting that berberine has relatively low oral bioavailability (approximately 5%), so much of the ingested dose remains in the gastrointestinal tract, which is advantageous for treating gut infections but limits systemic antibacterial effects.

Cycling Protocols

Most herbalists and naturopathic practitioners recommend using goldenseal in cycles rather than continuously. A common protocol involves using goldenseal for two to three weeks followed by a one to two week break before resuming. This cycling approach is recommended for several reasons: it prevents the potential for bacterial adaptation to chronic sub-inhibitory berberine exposure, it avoids the theoretical risk of disrupting beneficial gut flora with prolonged use, and it allows the mucous membranes to recover from the strongly astringent effects of the alkaloids. For acute infections, goldenseal is typically used at higher doses for a shorter duration (7-14 days), while for chronic or recurrent conditions, lower doses with cycling are preferred. The maximum recommended continuous use duration is generally three weeks without professional supervision.

Safety and Contraindications

While goldenseal has a long history of traditional use and is generally considered safe when used as directed, several important safety considerations and contraindications must be observed.

Key Research Papers and References

The following research areas and journals have contributed foundational knowledge to the scientific understanding of goldenseal's antibacterial properties and clinical applications.

Video Thumbnail

Top 3 Goldenseal Root Benefits and the Magic of Berberine

Video Thumbnail

The Unbelievable Benefits of Goldenseal for Mucus Relief

Video Thumbnail

What is Goldenseal?

Video Thumbnail

Goldenseal Benefit #1

Video Thumbnail

Goldenseal Benefit #2

Video Thumbnail

Goldenseal Benefit #3

Back to Table of Contents